wsbdaily | Mon, 26 Sep 2022 02:18:10 EST Where you find Tomorrow’s Hot Stocks Yesterday!
NOT INVESTMENT ADVICE: ALL CONTENT IS PROVIDED 'AS IS' FOR ENTERTAINMENT AND/OR INFORMATIONAL PURPOSES ONLY.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
WITHOUT WARRANTY OF ANY KIND. YOU BEAR ALL RISKS, INCLUDING ANY RELIANCE ON THE ACCURACY OF ANY INFORMATION.
WE ARE NOT AFFILIATED WITH THE WALLSTREETBETS NOR ANY OTHER COMMUNITY ON REDDIT.
Pfizer Inc.(PFE)
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 trea... Read More
Summary & Charts
| Price | $ 44.08 | -0.49 (-1.1%) |
| Day's Range | $ 43.58 - 44.56 | |
| Previous Close | $ 44.57 | |
| Market Cap | $ 247.39B USD | |
| Short Interest % | N/A | |
| Float | N/A | |
| Outstanding | N/A |
| Exchange | NYSE | |
| Industry | Drug Manufacturers—General | |
| Sector | Healthcare | |
| Volume | 18.87M | |
| Avg. Volume (20 day) | 17.73M | |
| Rel. Volume (20 day) | 1.06 | |
| Rel. Volume (3 month) | 1.06 | |
| Rating | A+ | Strong Buy |
| DCF | N/A | Strong Buy |
| Debt/Equity | 123.64 % | Buy |
| ROE | 36.35 % | Buy |
| ROA | 17.63 % | Neutral |
| P/E | 8.58 % | Buy |
| P/B | 2.83 % | Strong Buy |
| Date | Open | High | Low | Close | Change | Volume | R. Vol. (20d) | R. Vol. (3m) | Mentions |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2022 | $ 44.44 | $ 44.56 | $ 43.58 | $ 44.08 | -0.49 | 18,872,926 | 1.06 | 1.06 | |
| Sep 22, 2022 | $ 43.67 | $ 45.00 | $ 43.52 | $ 44.57 | +0.65 | 18,508,808 | 1.06 | 1.04 | 1 |
| Sep 21, 2022 | $ 44.81 | $ 44.98 | $ 43.90 | $ 43.92 | -0.85 | 17,506,858 | 1.01 | 0.96 | |
| Sep 20, 2022 | $ 45.00 | $ 45.27 | $ 44.44 | $ 44.77 | -0.67 | 15,370,312 | 0.89 | 0.84 | 5 |
| Sep 19, 2022 | $ 45.68 | $ 45.88 | $ 44.78 | $ 45.44 | -0.59 | 16,243,244 | 0.94 | 0.88 | 2 |
| Sep 16, 2022 | $ 46.09 | $ 46.62 | $ 45.64 | $ 46.03 | +0.09 | 30,630,619 | 1.78 | 1.64 | 4 |
| Sep 15, 2022 | $ 46.11 | $ 46.29 | $ 45.70 | $ 45.94 | -0.21 | 15,799,921 | 0.95 | 0.86 | 1 |
| Sep 14, 2022 | $ 46.20 | $ 46.41 | $ 45.78 | $ 46.15 | -0.04 | 17,163,026 | 1.04 | 0.93 | |
| Sep 13, 2022 | $ 47.13 | $ 47.32 | $ 46.02 | $ 46.19 | -1.57 | 16,596,540 | 1.02 | 0.90 | |
| Sep 12, 2022 | $ 48.08 | $ 48.35 | $ 47.69 | $ 47.76 | -0.08 | 13,557,057 | 0.84 | 0.71 | |
| Sep 09, 2022 | $ 47.20 | $ 47.99 | $ 47.10 | $ 47.84 | +0.76 | 17,502,174 | 1.04 | 0.90 | |
| Sep 08, 2022 | $ 46.02 | $ 47.12 | $ 45.87 | $ 47.08 | +0.95 | 18,265,326 | 1.01 | 0.94 | |
| Sep 07, 2022 | $ 45.70 | $ 46.21 | $ 45.38 | $ 46.13 | +0.37 | 15,369,443 | 0.85 | 0.79 | 2 |
| Sep 06, 2022 | $ 45.96 | $ 46.44 | $ 45.53 | $ 45.76 | +0.06 | 17,139,100 | 0.96 | 0.88 | |
| Sep 02, 2022 | $ 46.74 | $ 46.80 | $ 45.53 | $ 45.70 | -0.93 | 14,258,635 | 0.80 | 0.73 | 2 |
| Sep 01, 2022 | $ 45.14 | $ 46.65 | $ 45.14 | $ 46.63 | +1.40 | 19,130,809 | 1.07 | 0.98 | 2 |
| Aug 31, 2022 | $ 46.01 | $ 46.29 | $ 45.13 | $ 45.23 | -0.62 | 26,414,554 | 1.49 | 1.35 | 3 |
| Aug 30, 2022 | $ 46.34 | $ 46.35 | $ 45.80 | $ 45.85 | -0.38 | 16,296,680 | 0.95 | 0.84 | |
| Aug 29, 2022 | $ 46.38 | $ 46.69 | $ 46.12 | $ 46.23 | -0.59 | 13,400,939 | 0.77 | 0.69 | 1 |
| Aug 26, 2022 | $ 47.62 | $ 47.96 | $ 46.70 | $ 46.82 | -1.08 | 16,541,646 | 0.94 | 0.84 | 2 |
News
The latest news about Pfizer Inc. (PFE).
Reuters | 2022-09-24 16:20:06
Pfizer Inc Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19.
CNBC Television | 2022-09-22 18:04:27
Aadil Zaman, Wall Street Alliance Group, joins 'Closing Bell: Overtime' to discuss three stocks: Alphabet, Microsoft and Pfizer.
Market Watch | 2022-09-22 06:51:18
Pfizer Inc. PFE, -1.90% said Thursday it has reached an agreement to supply up to six million treatment courses of its COVID antiviral Paxlovid to the Global Fund for low and middle-income countries. The company said it expects supply to be available starting in 2022, pending regulatory authorization or approval and based on demand from individual countries.
Seeking Alpha | 2022-09-20 23:24:20
From 2Q 2021 to 2Q 2022, Pfizer's net income increased by 78% YoY to $9.9 billion. As of 19 September 2022, Pfizer/BioNTech vaccine doses administered globally decreased from 858000 per day in the second quarter to 566000 per day in the third quarter.
Seeking Alpha | 2022-09-20 10:49:52
The compelling results of endometriosis treatment MYFEMBREE's phase 3 led to the drug's approval, and Myovant will be eligible for up to $200 million based on achieving certain milestones. The endometriosis market currently has few competitors, and more generally, there are many opportunities in women's health drug development.
Seeking Alpha | 2022-09-20 10:04:38
Pfizer has expected 2022 sales of COMIRNATY remains at $32 billion and then $22 billion for PAXLOVID. A possible surge in Covid-19 cases in Fall of 2022 would mean improved sales of COMIRNATY and PAXLOVID, especially if the U.S. Government takes option to buy another 195 million vaccine doses.
Business Wire | 2022-09-20 10:00:00
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, November 1, 2022. The purpose of the call is to provide an update on Pfizer's results, as reflected in the company's Third Quarter 2022 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com/investors. Info
Earnings
| Date | Time | EPS Expected | EPS Reported | % | Revenue Expected | Revenue Reported | % |
|---|---|---|---|---|---|---|---|
| 2022-11-01 | BMO | 1.5 | -- | -- | 22B | -- | -- |
| 2022-07-28 | BMO | 1.78 | 2.04 | 14.6% | -- | -- | -- |
| 2022-05-03 | BMO | 1.47 | 1.67 | 13.6% | 22B | 26B | 15.74% |
| 2022-02-08 | BMO | 0.85 | 1.08 | 27.05% | 0.2T | 24B | -89.13% |
| 2021-11-02 | BMO | 1.08 | 1.34 | 24.07% | 22B | 24B | 7.65% |
| 2021-07-28 | BMO | 0.97 | 1.07 | 10.3% | 23B | 19B | -17.04% |
| 2021-05-04 | BMO | 0.77 | 0.93 | 20.77% | 14B | 15B | 7.6% |
| 2021-02-02 | BMO | 0.48 | 0.42 | -12.5% | 6.7B | 5.9B | -11.12% |
Top Discussions
These are the top discussions over the last 24-hours that mention the PFE stock ticker symbol.
Unusual Option Activity
Option contracts that are trading at a significantly higher volume relative to the contract's open interest. These might provide some insight into what "smart money" is doing with large volume orders.
| Type | Strike | Exp Date | DTE | Bid | Ask | Last | Volume | Open Interest | Vol/OI | IV |
|---|---|---|---|---|---|---|---|---|---|---|
| CALL | $ 43.00 | 09/29/22 | 4 | $ 1.43 | $ 1.59 | $ 1.41 | 28 | 22 | 1.27 | 0.43% |
| CALL | $ 43.50 | 09/29/22 | 4 | $ 1.09 | $ 1.15 | $ 0.90 | 145 | 44 | 3.30 | 0.37% |
| CALL | $ 44.00 | 09/29/22 | 4 | $ 0.76 | $ 0.84 | $ 0.77 | 809 | 229 | 3.53 | 0.35% |
| CALL | $ 44.50 | 09/29/22 | 4 | $ 0.53 | $ 0.61 | $ 0.56 | 673 | 296 | 2.27 | 0.35% |
| CALL | $ 45.50 | 09/29/22 | 4 | $ 0.21 | $ 0.25 | $ 0.21 | 561 | 393 | 1.43 | 0.33% |
| CALL | $ 51.50 | 09/29/22 | 4 | $ 0.01 | $ 0.02 | $ 0.04 | 170 | 63 | 2.70 | 0.55% |
| PUT | $ 43.00 | 09/29/22 | 4 | $ 0.33 | $ 0.37 | $ 0.35 | 10,742 | 289 | 37.17 | 0.36% |
| CALL | $ 44.00 | 10/06/22 | 11 | $ 1.08 | $ 1.18 | $ 1.12 | 486 | 15 | 32.40 | 0.34% |
| CALL | $ 49.00 | 10/06/22 | 11 | $ 0.03 | $ 0.05 | $ 0.03 | 416 | 278 | 1.50 | 0.33% |
| CALL | $ 54.00 | 10/06/22 | 11 | $ 0.00 | $ 0.03 | $ 0.04 | 201 | 43 | 4.67 | 0.51% |
| PUT | $ 42.00 | 10/06/22 | 11 | $ 0.33 | $ 0.39 | $ 0.37 | 96 | 59 | 1.63 | 0.35% |
| CALL | $ 46.00 | 10/27/22 | 32 | $ 0.80 | $ 0.93 | $ 0.82 | 1,189 | 67 | 17.75 | 0.31% |
| PUT | $ 36.00 | 10/27/22 | 32 | $ 0.08 | $ 0.16 | $ 0.09 | 406 | 55 | 7.38 | 0.44% |
| PUT | $ 40.00 | 10/27/22 | 32 | $ 0.39 | $ 0.47 | $ 0.46 | 22 | 12 | 1.83 | 0.36% |
| CALL | $ 23.00 | 01/19/23 | 116 | $ 23.80 | $ 24.30 | $ 29.15 | 90 | 10 | 9.00 | 1.43% |
| CALL | $ 40.00 | 03/16/23 | 172 | $ 6.00 | $ 6.25 | $ 5.90 | 228 | 133 | 1.71 | 0.34% |
| CALL | $ 45.00 | 03/16/23 | 172 | $ 3.15 | $ 3.25 | $ 3.10 | 374 | 195 | 1.92 | 0.30% |
| CALL | $ 47.50 | 03/16/23 | 172 | $ 2.11 | $ 2.24 | $ 2.17 | 5,704 | 1,123 | 5.08 | 0.29% |
| PUT | $ 27.50 | 03/16/23 | 172 | $ 0.22 | $ 0.30 | $ 0.25 | 2,624 | 37 | 70.92 | 0.45% |
| CALL | $ 50.00 | 01/16/25 | 844 | $ 4.65 | $ 5.55 | $ 5.40 | 3,893 | 2,020 | 1.93 | 0.29% |
Last Updated: Sat, 24 Sep 2022 21:30 EST
Failures to Deliver
Each point represents the aggregate net balance of shares that failed to be delivered as of a particular settlement date.
Please note that fails-to-deliver can occur for a number of reasons on both long and short sales. Therefore, fails-to-deliver are not necessarily the result of short selling, nor evidence of abusive “naked” short selling. For more information on short selling and fails-to-deliver, see Key Points About Regulation SHO, Division of Market Regulation, and Final Rule: Short Sales.
Last Updated: Mon, 13 Dec 2021 12:00 EST
@wsbdaily
wsbdaily